Christopher D. Pericone

1.6k total citations
29 papers, 1.2k citations indexed

About

Christopher D. Pericone is a scholar working on Epidemiology, Emergency Medicine and Immunology. According to data from OpenAlex, Christopher D. Pericone has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Emergency Medicine and 5 papers in Immunology. Recurrent topics in Christopher D. Pericone's work include Pneumonia and Respiratory Infections (4 papers), Legionella and Acanthamoeba research (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Christopher D. Pericone is often cited by papers focused on Pneumonia and Respiratory Infections (4 papers), Legionella and Acanthamoeba research (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Christopher D. Pericone collaborates with scholars based in United States, Netherlands and Switzerland. Christopher D. Pericone's co-authors include Jeffrey N. Weiser, Karin Overweg, Peter W. M. Hermans, Karim Suwwan de Felipe, Howard A. Shuman, Sunny Park, James A. Imlay, Xavier Charpentier, O. Roger Anderson and Moraima Reyes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Christopher D. Pericone

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher D. Pericone United States 11 428 411 409 272 139 29 1.2k
Midori Ogawa Japan 19 533 1.2× 205 0.5× 349 0.9× 346 1.3× 59 0.4× 69 1.1k
Christophe Carnoy France 20 245 0.6× 181 0.4× 537 1.3× 375 1.4× 90 0.6× 43 1.4k
Mariette Barbier United States 21 170 0.4× 246 0.6× 441 1.1× 106 0.4× 261 1.9× 59 1.1k
Terrence L. Stull United States 27 338 0.8× 459 1.1× 581 1.4× 70 0.3× 576 4.1× 62 1.8k
Hiroshi Watanabe Japan 23 143 0.3× 668 1.6× 417 1.0× 297 1.1× 329 2.4× 131 1.8k
C S Edén Sweden 14 657 1.5× 604 1.5× 564 1.4× 234 0.9× 196 1.4× 16 1.7k
Daniel A. Powell United States 15 121 0.3× 443 1.1× 1.0k 2.5× 826 3.0× 212 1.5× 31 2.1k
Carrie L. Shaffer United States 19 200 0.5× 171 0.4× 367 0.9× 447 1.6× 42 0.3× 33 1.5k
Carlo Zagaglia Italy 21 409 1.0× 249 0.6× 301 0.7× 94 0.3× 133 1.0× 38 974
S. Olling Sweden 24 792 1.9× 856 2.1× 480 1.2× 237 0.9× 138 1.0× 54 1.9k

Countries citing papers authored by Christopher D. Pericone

Since Specialization
Citations

This map shows the geographic impact of Christopher D. Pericone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Pericone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Pericone more than expected).

Fields of papers citing papers by Christopher D. Pericone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher D. Pericone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Pericone. The network helps show where Christopher D. Pericone may publish in the future.

Co-authorship network of co-authors of Christopher D. Pericone

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher D. Pericone. A scholar is included among the top collaborators of Christopher D. Pericone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher D. Pericone. Christopher D. Pericone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alberts, Mark J., et al.. (2025). Health Care Resource Use and Costs of Rivaroxaban Versus Warfarin Among Nonvalvular Atrial Fibrillation Polypharmacy Patients With Obesity. Journal of the American Heart Association. 14(2). e036401–e036401.
2.
3.
Chen, Yen‐Wen, David Anderson, Christopher D. Pericone, & Prina Donga. (2022). Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors. Journal of health economics and outcomes research. 9(1). 1–10. 8 indexed citations
4.
5.
LaMori, Joyce, et al.. (2022). Hepatitis vaccination adherence and completion rates and factors associated with low compliance: A claims-based analysis of U.S. adults. PLoS ONE. 17(2). e0264062–e0264062. 25 indexed citations
6.
7.
Wang, Kun, Wenze Tang, Jinghua He, et al.. (2021). Association of depression symptom severity with short-term risk of an initial hospital encounter in adults with major depressive disorder. BMC Psychiatry. 21(1). 257–257. 9 indexed citations
8.
9.
Blonde, Lawrence, Charmi Patel, Bingcao Wu, et al.. (2020). Real-World Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States. Advances in Therapy. 38(1). 594–606. 7 indexed citations
10.
Patel, Aarti A., et al.. (2020). Emergency Department Visits and Subsequent Hospital Admission Trends for Patients with Chest Pain and a History of Coronary Artery Disease. Cardiology and Therapy. 9(1). 153–165. 5 indexed citations
11.
Chen, Yen‐Wen, Hélène Hardy, Christopher D. Pericone, & Wing Chow. (2020). Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors. Journal of health economics and outcomes research. 7(2). 102–110. 13 indexed citations
12.
Walsh, Jessica A., et al.. (2020). Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies. Current Medical Research and Opinion. 36(7). 1245–1252. 13 indexed citations
13.
14.
15.
Wu, Bingcao, et al.. (2019). Total cost of care for castration-resistant prostate cancer in a commercially insured population and a medicare supplemental insured population. Journal of Medical Economics. 23(1). 54–63. 14 indexed citations
16.
17.
Patel, Aarti A., et al.. (2017). Abstract 204: Trends in Emergency Department Visits for Chest Pain Suggestive of Coronary Artery Disease and Shortness of Breath Suggestive of Congestive Heart Failure. Circulation Cardiovascular Quality and Outcomes. 10(suppl_3). 1 indexed citations
18.
Felipe, Karim Suwwan de, Xavier Charpentier, O. Roger Anderson, et al.. (2008). Legionella Eukaryotic-Like Type IV Substrates Interfere with Organelle Trafficking. PLoS Pathogens. 4(8). e1000117–e1000117. 227 indexed citations
19.
Felipe, Karim Suwwan de, et al.. (2005). Evidence for Acquisition of Legionella Type IV Secretion Substrates via Interdomain Horizontal Gene Transfer. Journal of Bacteriology. 187(22). 7716–7726. 232 indexed citations
20.
Pericone, Christopher D., et al.. (2003). Multiple mechanisms for choline transport and utilization in Haemophilus influenzae. Molecular Microbiology. 50(2). 537–548. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Midori Ogawa Breakdown of academic impact, for papers by Christophe Carnoy Breakdown of academic impact, for papers by Mariette Barbier Breakdown of academic impact, for papers by Terrence L. Stull Breakdown of academic impact, for papers by Hiroshi Watanabe Breakdown of academic impact, for papers by C S Edén Breakdown of academic impact, for papers by Daniel A. Powell Breakdown of academic impact, for papers by Carrie L. Shaffer Breakdown of academic impact, for papers by Carlo Zagaglia Breakdown of academic impact, for papers by S. Olling
Rankless by CCL
2026